Back to Search

DR. ANGELA PARDEE M.D.

M.D.

Internal Medicine Physician

NPI: 1053393611Individual

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

28789(NC)

Research & Publications (20)

Regulatory molecular biology.
PMID 16552190·Cell Cycle·2006
6-review
Tumor progression--targets for differential therapy.
PMID 17001691·J Cell Physiol·2006
6-review
Regulation in S phase by E2F.
PMID 15467444·Cell Cycle·2004
6-review
Beginnings of feedback inhibition, allostery, and multi-protein complexes.
PMID 14636988·Gene·2003
6-review
PaJaMas in Paris.
PMID 12414189·Trends Genet·2002
8-other
Regulation, restriction, and reminiscences.
PMID 12050173·J Biol Chem·2002
8-other
Cancer therapy with beta-lapachone.
PMID 12188909·Curr Cancer Drug Targets·2002
6-review
Metastasis and AKT activation.
PMID 18988188·J Cell Physiol·2009
6-review
IL-4 inhibits VLA-4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefit.
PMID 18958887·Eur J Immunol·2008
7-preclinical
CD8+ T-cell responses against hemoglobin-beta prevent solid tumor growth.
PMID 18829566·Cancer Res·2008
7-preclinical
Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo.
PMID 18566374·J Immunol·2008
7-preclinical
Metastasis and AKT activation.
PMID 18818526·Cell Cycle·2008
6-review
A devious cube of cancer.
PMID 18338337·J Cell Physiol·2008
8-other
Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation.
PMID 17545609·Cancer Res·2007
8-other
A protocol for differential display of mRNA expression using either fluorescent or radioactive labeling.
PMID 17406608·Nat Protoc·2007
8-other
Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
PMID 17620428·Mol Cancer Ther·2007
7-preclinical
Biomarkers, regerons, and pathways to lethal cancer.
PMID 17957698·J Cell Biochem·2007
6-review
Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine.
PMID 17283334·Proc Natl Acad Sci U S A·2007
8-other
Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs.
PMID 16408291·J Cell Biochem·2006
8-other
Crossroads of estrogen receptor and NF-kappaB signaling.
PMID 15956359·Sci STKE·2005
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
15825 BALLANTYNE MEDICAL PL STE 200
CHARLOTTE, NC 28277
Practice locations map

Location

Practice Location

15825 BALLANTYNE MEDICAL PL STE 200, CHARLOTTE, NC
(704) 384-1925

Quick Facts

NPI
1053393611
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile